rabbit anti integrin αvβ3 polyclonal antibody pab (Bioss)
Structured Review
Rabbit Anti Integrin αvβ3 Polyclonal Antibody Pab, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 60 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+%CE%B1v%CE%B23/Integrin+Alpha+V+%2B+Beta+3+Polyclonal+Antibody/pm41895769-53-38-46
Average 94 stars, based on 60 article reviews
Images
Related Articles
other:Article Title: Targeting BRIX1 via Engineered Exosomes Induces Nucleolar Stress to Suppress Cancer Progression Article Snippet: [ ] The anti‐Flag (Cat. No. F1804, Sigma‐Aldrich, St Louis, MO, USA), anti‐Myc (Cat. No. 60003‐2‐Ig, Proteintech), anti‐HA (Cat. No. 2367, Cell Signaling Technology, Danvers, MA, USA), anti‐BRIX1 (Cat. No. 17295‐1‐AP, Proteintech), anti‐p53 (Cat. No. sc‐126, DO‐1, Santa Cruz Biotechnology), anti‐MDM2 (Cat. No. ab16895, 2A10, Abcam), anti‐Phospho‐Histone H2A.X (Ser139) (Cat. No. 9718, Cell Signaling Technology), anti‐GAPDH (Cat. No. 60004‐1‐Ig, Proteintech), anti‐Tubulin (Cat. No. 66031‐1‐Ig, Proteintech), anti‐RPL5 (Cat. No. ab86863, Abcam), anti‐RPL11 (Cat. No. ab79352, Abcam), anti‐p21 (Cat. No. 2947, Cell Signaling Technology), anti‐NPM1 (Cat. No. sc‐271737, Santa Cruz Biotechnology), anti‐BOP1 (Cat. No.28366‐1‐AP, Proteintech), anti‐TSG101 (Cat. No. 28283‐1‐AP, Proteintech), anti‐CD81 (Cat. No. sc‐166029, Santa Cruz Biotechnology), anti‐CD9 (Cat. No. sc‐13118, Santa Cruz Biotechnology), anti‐COXIV (Cat. No. 11242‐1‐AP, Proteintech), and Staining:Article Title: Comparative analysis of engineered-exosome delivered si-HER2 and trastuzumab in the treatment of HER2-positive gastric cancer. Article Snippet: Trastuzumab is currently a key targeted drug for HER2-positive gastric cancer (GC), but there are common problems of drug resistance and cardiotoxicity in clinical treatment, resulting in poor therapeutic effects.. Exosomes are natural nanocarriers for drug delivery and engineered exosomes have been widely used in translational medicine research.. This study is designed to compare the anti-tumor effects and adverse effects between engineered exosomes carrying HER2 siRNA and trastuzumab. |
